Analysts’ Viewpoint
Rise in number of cancer cases is driving the demand for image-guided, minimally invasive surgical operations, which in turn is expected to propel the contrast media market growth during the forecast period. Furthermore, increase in demand for advanced and more accurate imaging procedures is likely to prompt leading players to launch new products and acquire approval for novel indications.
Key manufacturers of contrast enhancers and imaging contrast agents should increase investment in R&D activities for stronger imaging, and better patient diagnoses, treatment, and health. Moreover, rise in number of approvals for contrast agents and advancements in diagnostic modalities are estimated to offer lucrative contrast media market opportunities to manufacturers across the globe.
Imaging contrast agents are chemicals used in medical imaging procedures, such as X-rays, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, to improve the visibility of internal organs or structures in the human body. These agents or medications are taken orally or injected into the body.
Increase in aging population and incidence of chronic diseases is fueling the demand for accurate interventional diagnostics. Radiology, interventional radiology, and interventional cardiology depend on radiographic contrast agents to identify health disorders and determine treatment for patients. Moreover, contrast media is increasingly being utilized to detect cancer, gastrointestinal disorders, and neurological disorders.
Iodine-based contrast chemicals enhance the clarity of X-ray images and CAT scans. They improve visualization of the digestive tract, central nervous system, and various other interior organs. Furthermore, applications of ultrasonography have exceeded gynecology and obstetrics to include diagnosis of cancer, kidney stones, and the other clinical disorders. Thus, rise in demand for less intrusive instruments is boosting the demand for high-quality surgical imaging. This is a key factor driving the market revenue.
Contrast agents are generally considered safe in various diagnostic procedures; however, certain MRI contrast media side-effects and reactions associated with prolonged usage may hamper the contrast media market outlook in the near future. Furthermore, stringent regulations on the usage of these agents is also anticipated to restrain the contrast media industry progress during the forecast period.
According to the WHO, cancer is among the leading causes of fatalities across the globe. In 2020, around 10 million deaths were caused due to cancer alone. Contrast media provides a clear contrast between tissues, organs, and blood vessels, which helps physicians identify tumors or other abnormalities, and consequently, determine the course of treatment and patient care.
Therefore, rise in number of cases of cancer is driving the need for safe and effective diagnostic procedures such as CT scans, MRIs, and ultrasound, which in turn is estimated to propel the contrast media market size in the near future.
As per the American Cancer Society, among women in the U.S. in 2023, an estimated 297,790 cases of invasive breast cancer would be diagnosed, and 43,170 deaths are likely to occur. Early detection by mammography screening and improvements in imaging technology have contributed to declines in breast cancer death rates.
Among men and women in the U.S., an estimated 238,340 new cases of lung and bronchus cancer would be diagnosed in 2023. Lung cancer is the leading cause of cancer death for both men and women; about 127,070 deaths are expected to occur in 2023. Furthermore, the Society suggests lowering the recommended age to begin annual screening with a low-dose computed tomography (LDCT) scan to age 50 years.
According to the CDC, cancer screening can detect cancer at early stages before symptoms occur, and it can be more successfully treated. Screening is considered a major factor that can prevent thousands of cancer deaths. Modern mammography programs can reduce breast cancer mortality by more than 40%. Therefore, rise in screening rate for early detection of cancer is anticipated to boost the market in the near future.
North America accounted for the largest contrast media market share in 2022, with key players focusing on enhancement of healthcare facilities, thereby catering to higher demand for diagnostic procedures. In the U.S., syringeless injectors are witnessing high demand, as they help in delivery of precise dose of the contrast agents.
As per the National Center for Biotechnology Information, neurological disorders represent over 13.3% of total disability-adjusted life years (DALYs) and 19.5% of fatalities in the EU. This factor is expected to accelerate the demand for contrast media in Europe (as a measure of early diagnosis) during the forecast period.
According to the region-wise market analysis, the business in Asia Pacific is expected to grow at a rapid pace with leading players establishing subsidiaries in countries such as India and China. For instance, GE Pharmaceuticals (Shanghai) Co., Ltd. is one of the branches of GE in China for diagnostic drugs (CT/MR contrast agents).
The global contrast media industry is highly consolidated with few prominent companies accounting for majority market share. Leading players are following the latest contrast media market trends and focusing on regulatory approvals, expansion through mergers & acquisitions, collaborations, and partnerships, in order to consolidate their presence in the global market. A few prominent entities operating in the global market include GE Healthcare, Bayer AG, Bracco Diagnostic, Inc., Guerbet Group, Lantheus Medical Imaging, Inc., nanoPET Pharma GmbH, Subhra Pharma Pvt. Ltd., and Spago Nanomedical AB.
Key players in the contrast media market report have been profiled based on various parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 4.9 Bn |
| Market Forecast Value in 2031 | US$ 7.8 Bn |
| Growth Rate (CAGR) | 5.2% |
| Forecast Period | 2023-2031 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Regions Covered |
|
| Market Segmentation |
|
| Companies Profiled |
|
| Scope for Customization | Available upon Request |
| Pricing | Available upon Request |
The global media was valued at US$ 4.9 Bn in 2022
It is projected to grow at a CAGR of 5.2% from 2023 to 2031
Rise in prevalence of cancer and increase in demand for early diagnosis of cancer
In terms of application, the oncology segment held largest share in 2022
North America is estimated to dominate the global business in the next few years
GE Healthcare, Bayer AG, Bracco Diagnostic, Inc., Guerbet Group, Lantheus Medical Imaging, Inc., nanoPET Pharma GmbH, Subhra Pharma Pvt. Ltd., and Spago Nanomedical AB
1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Contrast Media Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Contrast Media Market Analysis and Forecast, 2022-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. List of Types of Diagnostic Imaging Tests
5.3. COVID-19 Pandemic Impact on Industry
6. Contrast Media Market Analysis and Forecast, by Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Iodine-based Compounds
6.3.2. Barium Sulfate-based Compounds
6.3.3. Gadolinium-based Compounds
6.3.4. Microbubbles/Microspheres
6.4. Market Attractiveness, by Type
7. Contrast Media Market Analysis and Forecast, by Administration
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Administration, 2017–2031
7.3.1. Oral
7.3.2. Rectal
7.3.3. Intravenous/Intrarterial
7.3.4. Others
7.3.5. 7.4 Market Attractiveness, by Administration
8. Global Contrast Media Market Analysis and Forecast, by Imaging Modality
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Imaging Modality, 2017–2031
8.3.1. CT/X-Ray
8.3.2. Ultrasound
8.3.3. MRI
8.3.4. Others
8.4. Market Attractiveness, by Imaging Modality
9. Global Contrast Media Market Analysis and Forecast, by Application
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Application, 2017–2031
9.3.1. Oncology
9.3.2. Cardiology
9.3.3. Neurology
9.3.4. Others
9.4. 9.4 Market Attractiveness, by Application
10. Global Contrast Media Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Contrast Media Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2031
11.2.1. Iodine-based Compounds
11.2.2. Barium Sulfate-based Compounds
11.2.3. Gadolinium-based Compounds
11.2.4. Microbubbles/Microspheres
11.3. Market Attractiveness, by Type
11.4. Market Value Forecast, by Administration, 2017–2031
11.4.1. Oral
11.4.2. Rectal
11.4.3. Intravenous/Intrarterial
11.4.4. Others
11.5. Market Attractiveness, by Administration
11.6. Market Value Forecast, by Imaging Modality, 2017–2031
11.6.1. CT/X-Ray
11.6.2. Ultrasound
11.6.3. MRI
11.6.4. Others
11.7. Market Attractiveness, by Imaging Modality
11.8. Market Value Forecast, by Application, 2017–2031
11.8.1. Oncology
11.8.2. Cardiology
11.8.3. Neurology
11.8.4. Others
11.9. Market Attractiveness, by Application
11.10. Market Value Forecast, by Country, 2022–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Type
11.11.2. By Administration
11.11.3. By Imaging Modality
11.11.4. Application
11.11.5. By Country
12. Europe Contrast Media Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. Iodine-based Compounds
12.2.2. Barium Sulfate-based Compounds
12.2.3. Gadolinium-based Compounds
12.2.4. Microbubbles/Microspheres
12.3. Market Attractiveness, by Type
12.4. Market Value Forecast, by Administration, 2017–2031
12.4.1. Oral
12.4.2. Rectal
12.4.3. Intravenous/Intrarterial
12.4.4. Others
12.5. Market Attractiveness, by Administration
12.6. Market Value Forecast, by Imaging Modality, 2017–2031
12.6.1. CT/X-Ray
12.6.2. Ultrasound
12.6.3. MRI
12.6.4. Others
12.7. Market Attractiveness, by Imaging Modality
12.8. Market Value Forecast, by Application, 2017–2031
12.8.1. Oncology
12.8.2. Cardiology
12.8.3. Neurology
12.8.4. Others
12.9. Market Attractiveness, by Application
12.10. Market Value Forecast, by Country/Sub-region, 2022–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Type
12.11.2. By Administration
12.11.3. By Imaging Modality
12.11.4. By Application
12.11.5. By Country/Sub-region
13. Asia Pacific Contrast Media Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2031
13.2.1. Iodine-based Compounds
13.2.2. Barium Sulfate-based Compounds
13.2.3. Gadolinium-based Compounds
13.2.4. Microbubbles/Microspheres
13.3. Market Attractiveness, by Type
13.4. Market Value Forecast, by Administration, 2017–2031
13.4.1. Oral
13.4.2. Rectal
13.4.3. Intravenous/Intrarterial
13.4.4. Others
13.5. Market Attractiveness, by Administration
13.6. Market Value Forecast, by Imaging Modality, 2017–2031
13.6.1. CT/X-Ray
13.6.2. Ultrasound
13.6.3. MRI
13.6.4. Others
13.7. Market Attractiveness, by Imaging Modality
13.8. Market Value Forecast, by Application, 2017–2031
13.8.1. Oncology
13.8.2. Cardiology
13.8.3. Neurology
13.8.4. Others
13.9. Market Attractiveness, by Application
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Type
13.11.2. By Administration
13.11.3. By Imaging Modality
13.11.4. By Application
13.11.5. By Country/Sub-region
14. Latin America Contrast Media Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2031
14.2.1. Iodine-based Compounds
14.2.2. Barium Sulfate-based Compounds
14.2.3. Gadolinium-based Compounds
14.2.4. Microbubbles/Microspheres
14.3. Market Attractiveness, by Type
14.4. Market Value Forecast, by Administration, 2017–2031
14.4.1. Oral
14.4.2. Rectal
14.4.3. Intravenous/Intrarterial
14.4.4. Others
14.5. Market Attractiveness, by Administration
14.6. Market Value Forecast, by Imaging Modality, 2017–2031
14.6.1. CT/X-Ray
14.6.2. Ultrasound
14.6.3. MRI
14.6.4. Others
14.7. Market Attractiveness, by Imaging Modality
14.8. Market Value Forecast, by Application, 2017–2031
14.8.1. Oncology
14.8.2. Cardiology
14.8.3. Neurology
14.8.4. Others
14.9. Market Attractiveness, by Application
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Type
14.11.2. By Administration
14.11.3. By Imaging Modality
14.11.4. By Application
14.11.5. By Country/Sub-region
15. Middle East & Africa Contrast Media Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017–2031
15.2.1. Iodine-based Compounds
15.2.2. Barium Sulfate-based Compounds
15.2.3. Gadolinium-based Compounds
15.2.4. Microbubbles/Microspheres
15.3. Market Attractiveness, by Type
15.4. Market Value Forecast, by Administration, 2017–2031
15.4.1. Oral
15.4.2. Rectal
15.4.3. Intravenous/Intrarterial
15.4.4. Others
15.5. Market Attractiveness, by Administration
15.6. Market Value Forecast, by Imaging Modality, 2017–2031
15.6.1. CT/X-Ray
15.6.2. Ultrasound
15.6.3. MRI
15.6.4. Others
15.7. Market Attractiveness, by Imaging Modality
15.8. Market Value Forecast, by Application, 2017–2031
15.8.1. Oncology
15.8.2. Cardiology
15.8.3. Neurology
15.8.4. Others
15.9. Market Attractiveness, by Application
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Type
15.11.2. By Administration
15.11.3. By Imaging Modality
15.11.4. By Application
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. GE Healthcare
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Type Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Bayer AG
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Type Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Bracco Diagnostic, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Type Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Guerbet Group
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Type Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Lantheus Medical Imaging, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Type Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. nanoPET Pharma GmbH
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Type Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Subhra Pharma Pvt. Ltd.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Type Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Spago Nanomedical AB
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Type Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
List of Tables
Table 1: Global Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 2: Global Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 3: Global Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031
Table 4: Global Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 5: Global Contrast Media Market Value (US$ Mn) Forecast, by Country/Region, 2017–2031
Table 6: North America Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 7: North America Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 8: North America Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031
Table 9: North America Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 10: Europe Contrast Media Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Europe Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 12: Europe Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 13: Europe Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031
Table 14: Europe Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 17: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 18: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031
Table 19: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 22: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 23: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031
Table 24: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 25: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 27: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 28: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031
Table 29: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031
List of Figures
Figure 1: Global Contrast Media Market Value (US$ Mn) Forecast, 2017–2031
Figure 2: Contrast Media Market Value Share, by Type, 2022
Figure 3: Contrast Media Market Value Share, by Administration, 2022
Figure 4: Contrast Media Market Value Share, by Imaging Modality, 2022
Figure 5: Contrast Media Market Value Share, by Application, 2022
Figure 6: Global Contrast Media Market Value Share Analysis, by Type 2022 and 2031
Figure 7: Global Contrast Media Market Attractiveness Analysis, Type, 2023–2031
Figure 8: Global Contrast Media Market Value Share Analysis, by Administration 2022 and 2031
Figure 9: Global Contrast Media Market Attractiveness Analysis, Administration, 2023–2031
Figure 10: Global Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031
Figure 11: Global Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031
Figure 12: Global Contrast Media Market Value Share Analysis, by Application 2022 and 2031
Figure 13: Global Contrast Media Market Attractiveness Analysis, Application, 2023–2031
Figure 14: Global Contrast Media Market Value Share Analysis, by Country, 2022 and 2031
Figure 15: Global Contrast Media Market Attractiveness Analysis, by Country, 2023–2031
Figure 16: North America Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 17: North America Contrast Media Market Value Share Analysis, by Type 2022 and 2031
Figure 18: North America Contrast Media Market Attractiveness Analysis, Type, 2023–2031
Figure 19: North America Contrast Media Market Value Share Analysis, by Administration 2022 and 2031
Figure 20: North America Contrast Media Market Attractiveness Analysis, Administration, 2023–2031
Figure 21: North America Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031
Figure 22: North America Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031
Figure 23: North America Contrast Media Market Value Share Analysis, by Application 2022 and 2031
Figure 24: North America Contrast Media Market Attractiveness Analysis, Application, 2023–2031
Figure 25: Europe Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 26: Europe Contrast Media Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 27: Europe Contrast Media Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 28: Europe Contrast Media Market Value Share Analysis, by Type 2022 and 2031
Figure 29: Europe Contrast Media Market Attractiveness Analysis, Type, 2023–2031
Figure 30: Europe Contrast Media Market Value Share Analysis, by Administration, 2022 and 2031
Figure 31: Europe Contrast Media Market Attractiveness Analysis, Administration, 2023–2031
Figure 32: Europe Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031
Figure 33: Europe Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031
Figure 34: Europe Contrast Media Market Value Share Analysis, by Application, 2022 and 2031
Figure 35: Europe Contrast Media Market Attractiveness Analysis, Application, 2023–2031
Figure 36: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 37: Asia Pacific Contrast Media Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 38: Asia Pacific Contrast Media Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 39: Asia Pacific Contrast Media Market Value Share Analysis, by Type 2022 and 2031
Figure 40: Asia Pacific Contrast Media Market Attractiveness Analysis, Type, 2023–2031
Figure 41: Asia Pacific Contrast Media Market Value Share Analysis, by Administration, 2022 and 2031
Figure 42: Asia Pacific Contrast Media Market Attractiveness Analysis, Administration, 2023–2031
Figure 43: Asia Pacific Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031
Figure 44: Asia Pacific Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031
Figure 45: Asia Pacific Contrast Media Market Value Share Analysis, by Application, 2022 and 2031
Figure 46: Asia Pacific Contrast Media Market Attractiveness Analysis, Application, 2023–2031
Figure 47: Latin America Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 48: Latin America Contrast Media Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 49: Latin America Contrast Media Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 50: Latin America Contrast Media Market Value Share Analysis, by Type 2022 and 2031
Figure 51: Latin America Contrast Media Market Attractiveness Analysis, Type, 2023–2031
Figure 52: Latin America Contrast Media Market Value Share Analysis, by Administration, 2022 and 2031
Figure 53: Latin America Contrast Media Market Attractiveness Analysis, Administration, 2023–2031
Figure 54: Latin America Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031
Figure 55: Latin America Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031
Figure 56: Latin America Contrast Media Market Value Share Analysis, by Application, 2022 and 2031
Figure 57: Latin America Contrast Media Market Attractiveness Analysis, Application, 2023–2031
Figure 58: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 59: Middle East & Africa Contrast Media Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 60: Middle East & Africa Contrast Media Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 61: Middle East & Africa Contrast Media Market Value Share Analysis, by Type 2022 and 2031
Figure 62: Middle East & Africa Contrast Media Market Attractiveness Analysis, Type, 2023–2031
Figure 63: Middle East & Africa Contrast Media Market Value Share Analysis, by Administration, 2022 and 2031
Figure 64: Middle East & Africa Contrast Media Market Attractiveness Analysis, Administration, 2023–2031
Figure 65: Middle East & Africa Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031
Figure 66: Middle East & Africa Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031
Figure 67: Middle East & Africa Contrast Media Market Value Share Analysis, by Application, 2022 and 2031
Figure 68: Middle East & Africa Contrast Media Market Attractiveness Analysis, Application, 2023–2031
Figure 69: Global Contrast Media Market Share Analysis, by Company, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Contrast Media Market
